ADAM10 and hepatocellular carcinoma: Efficient delivery enabled miR122 to effectively silence ADAM10 mRNA, and miR122 could inhibit the expression of drug efflux transporters, thereby overcoming hepatocellular carcinoma (HCC)’s resistance to PTX and sensitizing HepG2 cells to PTX treatment, and thus synergize with PTX.